新型冠狀病毒感染病人之慢性病藥物使用考量

Chronic Disease Drug Use in Patients with Coronavirus Disease (COVID-19)

陳立奇(Lih-Chi Chen)

《北市醫學雜誌》 預刊文章 Pp. 1-7

https://doi.org/10.6200/TCMJ.202009/PP.0009

摘要

2019新型冠狀病毒疾病（簡稱COVID-19）對於民眾日常之生活及健康照護，帶來極大之影響與衝擊。COVID-19重症病人常潛在三高慢性疾病（如糖尿病、高血壓、高血脂等心血管疾病），使其原本慢性病藥物之使用受到關注。近來有研究針對三高病人常用且與COVID-19可能有相關性之慢性用藥進行探討，尚無臨床資料證明其間之相關性及影響。故目前一般仍建議，對於COVID-19三高病人長期使用之慢性病用藥，仍宜在專業的評估監測下，維持其原有穩定之藥物治療，不宜貿然停藥，以免影響其慢性疾病之治療。COVID-19相關研究資料一直不斷更新，醫療照護者必須隨時關注最新的臨床資訊，方能提供符合最新治療建議之適當治療處置。

關鍵字

新型冠狀病毒疾病（COVID-19） ； 慢性病藥物

並列摘要

2019 new coronavirus disease (COVID-19) has brought great impacts to the daily life and health care of the public. Severe COVID-19 patients often have co-existing chronic diseases (such as diabetes, hypertension, hyperlipidemia, cardiovascular diseases, etc.), and the chronic disease drugs have been continuously used by the patients has been an issue of concern. Recent studies have explored the possible correlation between chronic medications related to high blood pressure, lipid, and glucose (such as angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, etc.) and COVID-19. However, as far as the current research data is concerned, there is no evidence to prove a correlation and an influence between them. Thus, it is generally recommended to continue the use of chronic medications in COVID-19 patients who have high blood pressure, lipid, and glucose under professional evaluation and monitoring to maintain a stable drug treatment (unless there are adverse drug reactions, contraindications, or other special considerations), and should not stop in rash to avoid affecting the treatment efficacy. The COVID-19 drug therapy related research data has been renewed continuously and medical caregivers should always attend to the latest clinical information to provide appropriate treatment and management in accordance with the newer treatment recommendations.

並列關鍵字

coronavirus-19 disease (COVID-19) ； drug for chronic disease